Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline

To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with locally advanced esophageal cancer. ASCO convened an Expert Panel to conduct a systematic review of the more recently published literature (1999-2019) on therapy options for patients with...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of clinical oncology Ročník 38; číslo 23; s. 2677
Hlavní autoři: Shah, Manish A, Kennedy, Erin B, Catenacci, Daniel V, Deighton, Dana C, Goodman, Karyn A, Malhotra, Narinder K, Willett, Christopher, Stiles, Brendon, Sharma, Prateek, Tang, Laura, Wijnhoven, Bas P L, Hofstetter, Wayne L
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 10.08.2020
Témata:
Combined Modality Therapy
Esophageal Neoplasms - pathology
Esophageal Neoplasms - therapy
Humans
Randomized Controlled Trials as Topic
ISSN:1527-7755, 1527-7755
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with locally advanced esophageal cancer. ASCO convened an Expert Panel to conduct a systematic review of the more recently published literature (1999-2019) on therapy options for patients with locally advanced esophageal cancer and provide recommended care options for this patient population. Seventeen randomized controlled trials met the inclusion criteria. Where possible, data were extracted separately for squamous cell carcinoma and adenocarcinoma. Multimodality therapy for patients with locally advanced esophageal carcinoma is recommended. For the subgroup of patients with adenocarcinoma, preoperative chemoradiotherapy or perioperative chemotherapy should be offered. For the subgroup of patients with squamous cell carcinoma, preoperative chemoradiotherapy or chemoradiotherapy without surgery should be offered. Additional subgroup considerations are provided to assist with implementation of these recommendations. Additional information is available at www.asco.org/gastrointestinal-cancer-guidelines.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Instructional Material/Guideline-3
content type line 23
ObjectType-Undefined-4
ISSN:1527-7755
1527-7755
DOI:10.1200/JCO.20.00866